BMPs may either act as tumor supporters, via promoting motility and invasiveness of some cancer cells, including prostate, colon and melanoma, or, on the contrary, limit the pro-metastatic aptitude of other cell lines, such as breast cancer cells. This evidence concerns the gene CLN5 and cancer.